History
| 1957 | Founded the South Japan Dog Center (with an animal hospital) in Kagoshima City
|
|---|---|
| 1960 | Started the contract business for safety testing (preclinical trials) as Japan's first pharmaceutical development contract research organization |
| 1974 | Changed the company name toSNBL Co., Ltd. |
| 1980 | A new Safety Research Institute was established in Yoshida Town, Kagoshima District (now Miyano-ura Town, Kagoshima City), and the headquarters was relocated. |
| 1982 | Succeeded in building the world's first online computer system in preparation for the enforcement of GLP (Good Laboratory Practice) standards for nonclinical safety testing of pharmaceuticals |
| 1983 | Obtained GLP compliance (first in Japan as a CRO) from the Ministry of Health, Labour and Welfare, and began safety testing. Expanded the research building |
| 1986 | Construction of a breeding facility for experimental NHP in Indonesia |
| 1988 | Opened a U.S. branch in Maryland as a sales base in the United States |
| 1989 | Commencement of breeding experimental NHP in China in collaboration with local companies |
| 1991 | Separated the U.S. branch as SNBL U.S.A., Ltd. Construction of a clinical pharmacology trial medical institution (CPC Clinic) in Kagoshima City |
| 1993 | Started the contract business for clinical pharmacology testing and Phase 1 clinical trials |
| 1997 | Established a new Translational Research (TR) business division |
| 1998 | A new drug metabolism analysis center has been established in Kainan City, Wakayama Prefecture, and contract services for analysis and pharmacokinetic testing have begun. |
| 1999 | Started the contract business for Phase 2 and Phase 3 clinical trials Relocation of SNBL U.S.A., Ltd to Everett, a suburb of Seattle, USA, and establishment of a new non-clinical testing facility 
|
| 2000 | SNBL U.S.A., Ltd: Obtained AAALAC International accreditation |
| 2003 | Construction of an experimental NHP breeding facility in Guangdong Province, China |
| 2004 | Listed on the Tokyo Stock Exchange Mothers Market Construction of a clinical pharmacology testing medical facility on the campus of the University of Maryland in Baltimore, USA |
| 2005 | Medipolis business launched |
| 2007 | Construction of an experimental NHP breeding facility in Cambodia |
| 2008 | Market change to the First Section of the Tokyo Stock Exchange |
| 2011 | Safety Research Institute: Obtained AAALAC International accreditation |
| 2015 | Wave Life Sciences, a nucleic acid pharmaceutical development company (established by us in 2012), listed on the NASDAQ market in the USA Joint ventureSNBL PPD Co., Ltd. was established. |
| 2019 | Satsuma Pharmaceuticals (established by us in 2016) listed on the NASDAQ market in the USA |
| 2022 | Transition to the Prime Market, a new market segment of the Tokyo Stock Exchange Consolidated Inari Research Inc. as a subsidiary |
| 2023 | Consolidated Satsuma Pharmaceuticals as a subsidiary |
| 2024 | Established a new research building at the Kagoshima headquarters
|